CHARLEVOIX—BioStar Capital, an investment firm focused on novel medical devices, announced that Jeffrey Yau, vice president of data science, data engineering, and platform engineering of store associate technologies at Walmart Global Technology, had joined BioStar as an entrepreneur in residence.
Yau was also previously Chief Data Scientist at AllianceBernstein, a global investment management and research firm with almost $700 billion in assets under management.
As an entrepreneur in residence, Yau will expand BioStar’s expertise within the emerging field of data science and artificial intelligence in healthcare, as well as identify and evaluate startups with high growth potential.
BioStar has invested in over 30 medical device startups, with nearly half acquired by major medical device manufacturers, including Boston Scientific, Medtronic, and Covidien.
“Over the past year and a half, the healthcare industry has experienced an immense amount of change ushering in a new era of technology-driven care with an increasing emphasis on cost efficient value-based models,” said Louis Cannon, M.D., founder and senior managing director of BioStar Capital. “Jeffrey has an extensive track record of success as a data science leader. His depth of experience, academic rigor, as well as his commitment to generating a positive impact on a societal level, will provide immense value to our team, startups, and patients around the world.”
Prior to AllianceBernstein, Yau was vice president and head of data science at Silicon Valley Data Science, where he led a team of data scientists helping Fortune 500 companies tackle business imperatives with data science and artificial intelligence. Yau also held several other leadership and data science positions, including the head of quantitative research and risk analytics at Charles Schwab Corp., director of financial risk consulting at KPMG, assistant director at Moody’s Analytics, and assistant professor of economics at Virginia Tech. He earned a Bachelor of Science in mathematics and economics from the University of California at Los Angeles and master’s and doctoral degrees in economics from the University of Pennsylvania.
“The healthcare industry has only scratched the surface of what’s possible with data-driven and AI-enabled technologies,” Yau said. “The BioStar team is well-positioned to get in on the ground floor of this trend, and I’m looking forward to identifying and nurturing startups who are shaping healthcare’s future and, just as importantly, making a meaningful impact on society as a whole.”
More at www.biostar.capital.
Wal-Mart data science expert to serve as BioStar entrepreneur-in-residence
CHARLEVOIX—BioStar Capital, an investment firm focused on novel medical devices, announced that Jeffrey Yau, vice president of data science, data engineering, and platform engineering of store associate technologies at Walmart Global Technology, had joined BioStar as an entrepreneur in residence.
Yau was also previously Chief Data Scientist at AllianceBernstein, a global investment management and research firm with almost $700 billion in assets under management.
As an entrepreneur in residence, Yau will expand BioStar’s expertise within the emerging field of data science and artificial intelligence in healthcare, as well as identify and evaluate startups with high growth potential.
BioStar has invested in over 30 medical device startups, with nearly half acquired by major medical device manufacturers, including Boston Scientific, Medtronic, and Covidien.
“Over the past year and a half, the healthcare industry has experienced an immense amount of change ushering in a new era of technology-driven care with an increasing emphasis on cost efficient value-based models,” said Louis Cannon, M.D., founder and senior managing director of BioStar Capital. “Jeffrey has an extensive track record of success as a data science leader. His depth of experience, academic rigor, as well as his commitment to generating a positive impact on a societal level, will provide immense value to our team, startups, and patients around the world.”
Prior to AllianceBernstein, Yau was vice president and head of data science at Silicon Valley Data Science, where he led a team of data scientists helping Fortune 500 companies tackle business imperatives with data science and artificial intelligence. Yau also held several other leadership and data science positions, including the head of quantitative research and risk analytics at Charles Schwab Corp., director of financial risk consulting at KPMG, assistant director at Moody’s Analytics, and assistant professor of economics at Virginia Tech. He earned a Bachelor of Science in mathematics and economics from the University of California at Los Angeles and master’s and doctoral degrees in economics from the University of Pennsylvania.
“The healthcare industry has only scratched the surface of what’s possible with data-driven and AI-enabled technologies,” Yau said. “The BioStar team is well-positioned to get in on the ground floor of this trend, and I’m looking forward to identifying and nurturing startups who are shaping healthcare’s future and, just as importantly, making a meaningful impact on society as a whole.”
More at www.biostar.capital.